Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo

(2011) S. Zhang et al.   CLINICAL CANCER RESEARCH

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

(2009) Mohammad Athar et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Angiogenic activity of sesamin through the activation of multiple signal pathways

(2009) Byung-Hee Chung et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Structural insight into human CK2α in complex with the potent inhibitor ellagic acid

(2009) Yusuke Sekiguchi et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Breast cancer as a global health concern

(2009) Steven S. Coughlin et al.   Cancer Epidemiology

Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling

(2009) J. Lu et al.   CARCINOGENESIS

Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway

(2009) Myung Hwan Jung et al.   CARCINOGENESIS

Tumoral angiogenesis and breast cancer

(2009) Parham Khosravi Shahi et al.   Clinical & Translational Oncology

Immunohistochemistry in the evaluation of neovascularization in tumor xenografts

(2008) D Wang et al.   BIOTECHNIC & HISTOCHEMISTRY

Grape Seed Extract Inhibits Angiogenesis via Suppression of the Vascular Endothelial Growth Factor Receptor Signaling Pathway

(2008) W. Wen et al.   Cancer Prevention Research